Rashmi Chugh, MD

Rashmi Chugh, MD, is a clinical professor and service chief of Internal Medicine at the University of Michigan Medical School, as well as an oncologist at the University of Michigan Rogel Cancer Center in Ann Arbor.

Articles by Rashmi Chugh, MD

Positive Phase 3 Data Drive Varegacestat Development in Desmoid Tumors: With Rashmi Chugh MD

ByRashmi Chugh, MD

February 26th 2026

Rashmi Chugh, MD, discusses the ongoing development of the investigational γ-secretase inhibitor varegacestat for patients with desmoid tumors.

Rashmi Chugh, MD

Articles by Rashmi Chugh, MD

Positive Phase 3 Data Drive Varegacestat Development in Desmoid Tumors: With Rashmi Chugh MD

Latest Updated Articles

Trending on OncLive

HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA

TALAPRO-3 Shows Talazoparib Plus Enzalutamide Improves rPFS in HRR-Altered mCSPC

Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis

Dr Eads on Early Data for CDH17-Directed CAR T-Cell Therapy in R/R GI Cancers

Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg